Acute decompensated heart failure

There are 96 papers on acute decompensated heart failure in aging research: 17 trials and 68 observational studies in people, 6 reviews. The newest story, Nov 18, 2026: “Movement program improved walking in heart failure patients”.

Disease

96 papers study it49 more mention it6 findings

14 new papers in 30 daysSee all 145 papers on acute decompensated heart failure

“Participants with preexisting CSD had a higher risk for acute decompensated heart failure.”
Incidence and prognosis of cardiac conduction system diseases in hypertension: the STEP trialNature aging2024doi:10.1038/s43587-024-00591-6
  • Human trial17
  • Humans68

Associations

4

SGLT2 inhibitors

downin humans3HR 0.72

3 studies
  1. SGLT2 inhibitors are linked with a lower risk of acute decompensated heart failure in humans (propensity-matched cohort) (mHR 0.578 (95% CI 0.34–0.99)).

    Humanspropensity-matched cohortup to 3 yearsn = 620

  2. SGLT2 inhibitors are linked with a lower risk of acute decompensated heart failure in propensity-matched patients with HFrEF and ESRD on dialysis (35.7% vs. 45.1%; risk difference -9.4%).

    Humansin propensity-matched patients with HFrEF and ESRD on dialysis540-day follow-upn = 8,168

  3. SGLT2 inhibitors are linked with a lower risk of acute decompensated heart failure in humans (HFpEF with ESRD, propensity-matched retrospective TriNetX cohort) (HR 0.72, 95% CI 0.67-0.77).

    HumansHFpEF with ESRD, propensity-matched retrospective TriNetX cohort18 monthsn = 7,238

More on SGLT2 inhibitors

Cardiac conduction system disease

upin humans1

1 study
  1. Cardiac conduction system disease raises the risk of acute decompensated heart failure in elderly hypertensive patients.

    Human trialin elderly hypertensive patients

More on Cardiac conduction system disease

Physical function

downin humans1

1 study
  1. Acute decompensated heart failure is associated with physical function in humans (Short Physical Performance Battery score 5.3 ± 2.8; 6-minute walk distance 178 ± 102 m).

    Humanshospitalized with acute decompensated heart failure; compared with age-matched stable heart failure and healthy cohortsn = 27

Frailty

upin humans1

1 study
  1. Acute decompensated heart failure is associated with frailty in humans (56% versus 0%).

    Humanshospitalized with acute decompensated heart failure; compared with age-matched chronic heart failure and healthy cohortsn = 27

Trial sponsors

Latest

Dec 2025: 4Jan 2026: 2Feb 2026: 5Mar 2026: 3Apr 2026: 0May 2026: 3Jun 2026: 1Jul 2026: 2Aug 2026: 1Sep 2026: 2Oct 2026: 11Nov 2026: 438 papers in 12 months
Heart & Lung

Movement program improved walking in heart failure patients

The program improved six-minute walking distance by an estimated 16.91 meters compared with routine care in a randomized trial of 174 hospitalized patients.The program improved six-minute walking distance by an estimated 16.91 meters compared with routine care in a randomized trial of 174 hospitalized patients.

Randomized trial · 174 peopleInterventions
JAMA Network Open

Indoor radon linked to heart failure in postmenopausal women

Women in counties above 4 picocuries per liter had a heart failure hazard ratio of 1.19 versus those below 2 picocuries per liter.Women in counties above 4 picocuries per liter had a heart failure hazard ratio of 1.19 versus those below 2 picocuries per liter.

Cohort · 43,188 peopleHeart failure
The Journals of Gerontology, Series A

Inflammation markers linked to poorer physical recovery

In older adults hospitalized for heart failure, rising markers were linked to 49.7 meters less improvement in six-minute walking distance over three months.In older adults hospitalized for heart failure, rising markers were linked to 49.7 meters less improvement in six-minute walking distance over three months.

Cohort · 226 peopleBiomarkers
ESC Congress 2026 Abstract

Four heart failure drugs linked to fewer deaths in older adults

Thirty-day mortality was 2.9% among older patients discharged on all four recommended drug types, versus 19.1% among those prescribed three or fewer.Thirty-day mortality was 2.9% among older patients discharged on all four recommended drug types, versus 19.1% among those prescribed three or fewer.

Cohort · 1,868 peoplePopulations
ESC Congress 2026 Abstract

Higher blood-marker levels linked to worse heart failure outcomes

The adjusted hazard ratio, a measure of relative risk, was 1.64 for cardiovascular death or worsening heart failure over two months, comparing highest versus lowest…The adjusted hazard ratio, a measure of relative risk, was 1.64 for cardiovascular death or worsening heart failure over two months, comparing highest versus lowest blood-marker groups.

Randomized trial · 2,400 peopleBiomarkers

See all 145 papers on acute decompensated heart failure